Chargement en cours...
Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
Pancreatic cancer is one of the deadliest cancers, ranking fourth among cancer-related deaths. Despite all the major molecular advances and treatment breakthroughs, mainly targeted therapies, the cornerstone treatment of metastatic pancreatic cancer (mPC) remains cytotoxic chemotherapy. In 2016, mor...
Enregistré dans:
| Publié dans: | World J Gastroenterol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155171/ https://ncbi.nlm.nih.gov/pubmed/28028360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i46.10124 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|